Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 77.0 | 81 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 163.0 | 72 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 204.0 | 87 | |
RA1869 | TNF-a | 100 | ng/mL | 3 | SCGF-b | 160.0 | 83 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 321.0 | 73 | |
N2759 | TNF-a | 100 | ng/mL | 3 | SCGF-b | 271.5 | 60 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 193.0 | 62 | |
RA1931 | TNF-a | 100 | ng/mL | 3 | SCGF-b | 170.5 | 58 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 236.0 | 56 | |
N2586 | TNF-a | 100 | ng/mL | 3 | SCGF-b | 259.5 | 50 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | SCGF-b | 146.5 | 66 | ||||
RA1869 | IKK16 | 2.0 | uM | 3 | SCGF-b | 154.5 | 86 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 3 | SCGF-b | 147.5 | 86 | ||||
N2759 | IKK16 | 2.0 | uM | 3 | SCGF-b | 120.0 | 86 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 3 | SCGF-b | 104.0 | 82 | ||||
RA1931 | IKK16 | 2.0 | uM | 3 | SCGF-b | 129.5 | 82 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 3 | SCGF-b | 116.0 | 72 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | SCGF-b | 100.0 | 68 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 3 | SCGF-b | 165.5 | 64 | ||||
RA1869 | 3 | SCGF-b | 145.0 | 60 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 3 | SCGF-b | 117.5 | 54 | ||||
N2759 | 3 | SCGF-b | 131.0 | 65 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 3 | SCGF-b | 133.0 | 69 | ||||
RA1931 | 3 | SCGF-b | 92.0 | 56 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 3 | SCGF-b | 91.0 | 51 |